John A. Colwell

Title
InstitutionMedical University of South Carolina
DepartmentEndocrinology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86. PMID: 20579547.
      Citations:    
    2. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402. PMID: 20508233.
      Citations:    
    3. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22; 121(24):2694-701. PMID: 20508178.
      Citations:    
    4. Colwell JA. Does aspirin use reduce cardiovascular risk in diabetes? Nat Rev Endocrinol. 2009 Apr; 5(4):188-90. PMID: 19352314.
      Citations:    
    5. Mountford WK, Lackland DT, Soule JB, Hunt KJ, Lipsitz SR, Colwell JA. Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients. Ethn Dis. 2008; 18(2):131-5. PMID: 18507262.
      Citations:    
    6. Mountford WK, Soule JB, Lackland DT, Lipsitz SR, Colwell JA. Diabetes-related lower extremity amputation rates fall significantly in South Carolina. South Med J. 2007 Aug; 100(8):787-90. PMID: 17713304.
      Citations:    
    7. Colwell JA. An appraisal of aspirin therapy in diabetes. Curr Diab Rep. 2006 Dec; 6(6):409-10. PMID: 17118221.
      Citations:    
    8. Colwell JA. Aspirin for the primary prevention of cardiovascular events. Timely Top Med Cardiovasc Dis. 2006 Oct 01; 10:E25. PMID: 17066145.
      Citations:    
    9. Koopman RJ, Mainous AG, Liszka HA, Colwell JA, Slate EH, Carnemolla MA, Everett CJ. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med. 2006 Sep-Oct; 4(5):427-32. PMID: 17003143.
      Citations:    
    10. Colwell JA. Aspirin for the primary prevention of cardiovascular events. Drugs Today (Barc). 2006 Jul; 42(7):467-79. PMID: 16894401.
      Citations:    
    11. Colwell JA. Is aspirin effective in diabetic patients? Yes. J Thromb Haemost. 2005 Dec; 3(12):2612-4. PMID: 16359499.
      Citations:    
    12. Colwell JA. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs. 2004; 4(2):87-106. PMID: 15049721.
      Citations:    
    13. Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S72-3. PMID: 14693931.
      Citations:    
    14. Colwell JA. Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 2003 Dec; 26(12):3349-50. PMID: 14633827.
      Citations:    
    15. Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8. PMID: 12832332.
      Citations:    
    16. Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 2003 Jan; 26 Suppl 1:S87-8. PMID: 12502626.
      Citations:    
    17. Colwell JA. Hemoglobin A1c is not the only issue. Curr Diab Rep. 2002 Aug; 2(4):295-6. PMID: 12643188.
      Citations:    
    18. Colwell JA. Treatment for the procoagulant state in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):1011-30. PMID: 11727398.
      Citations:    
    19. Colwell JA. Aspirin therapy in diabetes is underutilized. Diabetes Care. 2001 Feb; 24(2):195-6. PMID: 11213864.
      Citations:    
    20. Colwell J. Pathogenesis of vascular disease. Diabetes Obes Metab. 2000 Nov; 2 Suppl 2:S19-24. PMID: 11210241.
      Citations:    
    21. Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care. 2000 Oct; 23(10):1478-85. PMID: 11023140.
      Citations:    
    22. Pitale SU, Abraira C, Emanuele NV, McCarren M, Henderson WG, Pacold I, Bushnell D, Colwell JA, Nuttall FQ, Levin SR, Sawin CT, Comstock JP, Silbert CK. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 2000 Sep; 23(9):1316-20. PMID: 10977025.
      Citations:    
    23. Colwell JA, Keisler D, Todd-Heckel E, Arnold P, Jenkins C. New legislation covers reimbursement and diabetes care guidelines. J S C Med Assoc. 2000 Sep; 96(9):382-5. PMID: 11043014.
      Citations:    
    24. Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR, Nuttall FQ, Comstock JP, Sawin CT, Silbert C, Rubino FA. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999 Sep-Dec; 13(5-6):307-13. PMID: 10765007.
      Citations:    
    25. Colwell JA. Aspirin and risk of hemorrhagic stroke. JAMA. 1999 Aug 25; 282(8):731-2; author reply 732-3. PMID: 10463702.
      Citations:    
    26. Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus. Arch Intern Med. 1998 Dec 7-21; 158(22):2485-90. PMID: 9855387.
      Citations:    
    27. Willi SM, O'Rear D, Garvey WT, Colwell JA, Buse MG, Jaffa A, Lopes-Virella M, Wood D, Mayfield RK, Wallace P, Hermayer KL, Jenkins AJ, Lyons T, Mayer-Davis E. Diabetes research in South Carolina: past, present, and future. J S C Med Assoc. 1998 Nov; 94(11):502-8. PMID: 9844316.
      Citations:    
    28. Colwell JA, Keisler D, Jenkins C, Boateng Y, Arnold P, Lackland D, Zheng D, Wheeler FC, Rosebrock G, Smith SH. Overview of the Diabetes Initiative of South Carolina. J S C Med Assoc. 1998 Nov; 94(11):468-72. PMID: 9844311.
      Citations:    
    29. Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 1998 Apr; 21(4):510-5. PMID: 9571333.
      Citations:    
    30. Abraira C, Colwell JA, Nuttall F, Emanuele N, Comstock J, Levin S, Sawin C, Silbert C. A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care. 1998 Apr; 21(4):669-71. PMID: 9571364.
      Citations:    
    31. Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Diabetes Care. 1998 Apr; 21(4):574-9. PMID: 9571345.
      Citations:    
    32. Colwell JA. Prevention of diabetes complications. Clin Cornerstone. 1998; 1(3):58-71. PMID: 10682173.
      Citations:    
    33. Colwell JA. Elevated plasma homocysteine and diabetic vascular disease. Diabetes Care. 1997 Dec; 20(12):1805-6. PMID: 9405897.
      Citations:    
    34. Zheng D, Learner M, Wheeler FC, Macera CA, Boateng Y, Shepard DM, Colwell JA. Preventive care among people with diabetes in biracial population. J S C Med Assoc. 1997 Dec; 93(12):443-7. PMID: 9439106.
      Citations:    
    35. Colwell JA. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4. PMID: 9439550.
      Citations:    
    36. Colwell JA. Controlling type 2 diabetes: are the benefits worth the costs? JAMA. 1997 Nov 26; 278(20):1700. PMID: 9388092.
      Citations:    
    37. Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 1997 Nov; 20(11):1767-71. PMID: 9353620.
      Citations:    
    38. Colwell JA. Pharmacological strategies to prevent macrovascular disease in NIDDM. Diabetes. 1997 Sep; 46 Suppl 2:S131-4. PMID: 9285515.
      Citations:    
    39. Colwell JA. Aspirin therapy in diabetes mellitus. Diabetologia. 1997 Jul; 40(7):867. PMID: 9243111.
      Citations:    
    40. Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997 Jan 27; 157(2):181-8. PMID: 9009975.
      Citations:    
    41. Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Diabetes Care. 1996 Dec; 19(12):1375-81. PMID: 8941467.
      Citations:    
    42. Colwell JA. Should we use intensive insulin therapy after oral agent failure in type II diabetes? Diabetes Care. 1996 Aug; 19(8):896-8. PMID: 8842613.
      Citations:    
    43. Colwell JA. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90. PMID: 8674902.
      Citations:    
    44. Colwell JA. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):131-5. PMID: 8554205.
      Citations:    
    45. Colwell JA, Clark CM. Forum Two: Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):178-9. PMID: 8554215.
      Citations:    
    46. Jokl R, Klein RL, Lopes-Virella MF, Colwell JA. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes. Diabetes Care. 1995 Aug; 18(8):1150-5. PMID: 7587850.
      Citations:    
    47. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995 Aug; 18(8):1113-23. PMID: 7587846.
      Citations:    
    48. Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA. Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994 Aug; 17(8):818-23. PMID: 7956624.
      Citations:    
    49. Colwell JA. Is it time to introduce metformin in the U.S.? Diabetes Care. 1993 Apr; 16(4):653-5. PMID: 8462396.
      Citations:    
    50. Vinik AI, Colwell JA. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators. Diabetes Care. 1993 Jan; 16(1):37-44. PMID: 8422814.
      Citations:    
    51. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993 Jan; 42(1):8-11. PMID: 8420821.
      Citations:    
    52. Laber-Laird K, Smith A, Swindle MM, Colwell J. Effects of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab Anim Sci. 1992 Dec; 42(6):579-81. PMID: 1479810.
      Citations:    
    53. Abraira C, Emanuele N, Colwell J, Henderson W, Comstock J, Levin S, Nuttall F, Sawin C. Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes Care. 1992 Nov; 15(11):1560-71. PMID: 1308130.
      Citations:    
    54. Colwell JA. Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 1992 May; 41(5 Suppl 1):7-10. PMID: 1574016.
      Citations:    
    55. Colwell JA. Clinical trials of antiplatelet agents in diabetes mellitus: rationale and results. Semin Thromb Hemost. 1991 Oct; 17(4):439-44. PMID: 1803515.
      Citations:    
    56. Colwell JA. Pathophysiology of vascular disease in diabetes: effects of gliclazide. Am J Med. 1991 Jun 24; 90(6A):50S-54S. PMID: 1872305.
      Citations:    
    57. Colwell JA. Oral treatment of diabetes mellitus: the contribution of gliclazide. Am J Med. 1991 Jun 24; 90(6A):1S-2S. PMID: 1872299.
      Citations:    
    58. Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchick J, Colwell JA. Hemostatic alterations with exercise conditioning in NIDDM. Diabetes Care. 1990 Feb; 13(2):87-92. PMID: 2112452.
      Citations:    
    59. Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, Nuttall F. V.A. Cooperative Study of antiplatelet agents in diabetic patients after amputation for gangrene: unobserved, sudden, and unexpected deaths. J Diabet Complications. 1989 Oct-Dec; 3(4):191-7. PMID: 2533210.
      Citations:    
    60. Watanabe J, Wohltmann HJ, Klein RL, Colwell JA, Lopes-Virella MF. Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients. Diabetes. 1988 Dec; 37(12):1652-7. PMID: 3192039.
      Citations:    
    61. Colwell JA, Lopes-Virella MF. A review of the development of large-vessel disease in diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):113-8. PMID: 3057888.
      Citations:    
    62. Colwell JA. President's address. Diabetes. 1988 Nov; 37(11):1449-52. PMID: 3053300.
      Citations:    
    63. Colwell JA. Antiplatelet agents and diabetic vascular disease. Trans Am Clin Climatol Assoc. 1987; 98:119-27. PMID: 3303615.
      Citations:    
    64. Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF. Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia. 1986 Oct; 29(10):685-9. PMID: 3803742.
      Citations:    
    65. Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, Nuttall F. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr; 9(2):140-8. PMID: 3516608.
      Citations:    
    66. Colwell JA, Bingham SF. VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis. Haemostasis. 1986; 16(6):433-8. PMID: 3556347.
      Citations:    
    67. Lopes-Virella MF, Sherer G, Wohltmann H, Sens D, Colwell JA. Diabetic lipoprotein deficient serum: its effect in low density lipoprotein (LDL) uptake and degradation by fibroblasts. Metabolism. 1985 Dec; 34(12):1079-85. PMID: 2999561.
      Citations:    
    68. Halushka PV, Mayfield R, Colwell JA. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6. PMID: 3934501.
      Citations:    
    69. Mayfield RK, Halushka PV, Wohltmann HJ, Lopes-Virella M, Chambers JK, Loadholt CB, Colwell JA. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33. PMID: 3930325.
      Citations:    
    70. Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. Horm Metab Res Suppl. 1985; 15:69-73. PMID: 3908283.
      Citations:    
    71. Mayfield RK, Margolius HS, Levine JH, Wohltmann HJ, Loadholt CB, Colwell JA. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J Clin Endocrinol Metab. 1984 Aug; 59(2):278-86. PMID: 6564131.
      Citations:    
    72. Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics. Control Clin Trials. 1984 Jun; 5(2):165-83. PMID: 6378522.
      Citations:    
    73. Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80. PMID: 6424441.
      Citations:    
    74. Mayfield RK, Sullivan FM, Colwell JA, Wohltmann HJ. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics. Diabetes. 1983 Oct; 32(10):908-14. PMID: 6352376.
      Citations:    
    75. Mordes DB, Lazarchick J, Colwell JA, Sens DA. Elevated glucose concentrations increase factor VIIIR:Ag levels in human umbilical vein endothelial cells. Diabetes. 1983 Sep; 32(9):876-8. PMID: 6414864.
      Citations:    
    76. Colwell JA, Winocour PD, Halushka PV. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 May; 32 Suppl 2:14-9. PMID: 6242836.
      Citations:    
    77. Lopes-Virella MF, Wohltmann HJ, Mayfield RK, Loadholt CB, Colwell JA. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes. 1983 Jan; 32(1):20-5. PMID: 6336700.
      Citations:    
    78. Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia. 1982 Jun; 22(6):430-6. PMID: 7049800.
      Citations:    
    79. Van Zile J, Kilpatrick M, Laimins M, Sagel J, Colwell J, Virella G. Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes. 1981 Jul; 30(7):575-9. PMID: 7250529.
      Citations:    
    80. Colwell JA. Atherosclerosis in diabetes mellitus. J Chronic Dis. 1981; 34(1):1-4. PMID: 7005253.
      Citations:    
    81. Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb; 4(1):121-33. PMID: 7009108.
      Citations:    
    82. Halushka PV, Mayfield R, Wohltmann HJ, Rogers RC, Goldberg AK, McCoy SA, Loadholt CB, Colwell JA. Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8. PMID: 6795072.
      Citations:    
    83. Colwell JA, Halushka PV. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6. PMID: 6769461.
      Citations:    
    84. Gonzalez J, Colwell JA, Sarji KE, Nair RM, Sagel J. Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus. Thromb Res. 1980 Jan 1-15; 17(1-2):261-6. PMID: 6990548.
      Citations:    
    85. Colwell JA, Nair RM, Halushka PV, Rogers C, Whetsell A, Sagel J. Platelet adhesion and aggregation in diabetes mellitus. Metabolism. 1979 Apr; 28(4 Suppl 1):394-400. PMID: 122293.
      Citations:    
    86. Colwell JA, Halushka PV, Sarji KE, Sagel J. Platelet function and diabetes mellitus. Med Clin North Am. 1978 Jul; 62(4):753-66. PMID: 355740.
      Citations:    
    87. Colwell JA, Halushka PV, Sarji KE, Sagal J. Rationale for antiplatelet agents in diabetic vascular disease. Adv Exp Med Biol. 1978; 102:243-54. PMID: 356561.
      Citations:    
    88. Graves JM, Colwell JA, Nair RM, Sarji KE. The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects. Clin Endocrinol (Oxf). 1977 Jun; 6(6):437-42. PMID: 301801.
      Citations:    
    89. Colwell JA, Sagel J, Crook L, Chambers A, Laimins M. Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease. Metabolism. 1977 Mar; 26(3):279-85. PMID: 319323.
      Citations:    
    90. Colwell JA, Halushka PV, Sarji K, Levine J, Sagel J, Nair RM. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31. PMID: 823064.
      Citations:    
    91. Colwell JA, Chambers A, Laimins M. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus. Diabetes. 1975 Jul; 24(7):684-7. PMID: 1158034.
      Citations:    
    92. Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med. 1975 Jun; 82(6):733-8. PMID: 1138583.
      Citations:    
    93. Sorensen LB, Tesar JT, Ellman MH, Colwell J. A new case of xanthinuria. Am J Med. 1972 Nov; 53(5):690-2. PMID: 5079766.
      Citations:    
    94. Kwaan HC, Colwell JA, Suwanwela N. Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes. 1972 Feb; 21(2):108-13. PMID: 4621843.
      Citations:    
    95. Colwell JA, Cruz SR. Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis. Diabetes. 1972 Jan; 21(1):13-5. PMID: 5008082.
      Citations:    
    96. Colwell JA, Wilber JF. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia. Diabetes. 1971 Sep; 20(9):607-14. PMID: 4328691.
      Citations:    
    97. Colwell JA. Pheochromocytoma and insulin. Ann Intern Med. 1969 Sep; 71(3):668-9. PMID: 5809699.
      Citations:    
    98. Colwell JA. Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med. 1969 Aug; 71(2):251-6. PMID: 5800291.
      Citations:    
    99. Colwell JA, Furey WL. Insulin secretion by insuloma and normal pancreas slices. Studies in a patient with multiple endocrine adenomata. Diabetes. 1968 Feb; 17(2):83-9. PMID: 4295088.
      Citations:    
    100. Colwell JA, Lein A. Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes. 1967 Aug; 16(8):560-5. PMID: 6041184.
      Citations:    
    101. Colwell JA. Effect of diabetic control on retinopathy. Diabetes. 1966 Jul; 15(7):497-9. PMID: 5329504.
      Citations:    
    102. Colwell JA, Colwell AR. Effect of insulin infusion of pancreas on blood glucose. Diabetes. 1966 Feb; 15(2):123-6. PMID: 5907155.
      Citations:    
    103. COLWELL JA, LEIN A. QUANTITATIVE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF FATTY ACIDS AND GLUCOSE IN NORMAL AND DIABETIC DOGS. Diabetes. 1963 Sep-Oct; 12:424-8. PMID: 14067740.
      Citations:    
    104. COLWELL JA, LEIN A. EFFECT OF SITE OF ADMINISTRATION OF INSULIN ON BLOOD GLUCOSE AND FATTY ACID CONCENTRATIONS. Diabetes. 1963 Jul-Aug; 12:319-22. PMID: 14081843.
      Citations:    
    105. COLWELL JA, TILLMAN SP. Early recognition and therapy of disseminated coccidioidomycosis. Am J Med. 1961 Nov; 31:676-91. PMID: 13880720.
      Citations:    
    106. COLWELL JA. Remission in disseminated coccidiodomycosis produced by amphotericin B. Ann Intern Med. 1959 Apr; 50(4):1028-35. PMID: 13637573.
      Citations:    
    107. COLWELL AR, COLWELL JA. Intrapancreatic infusions of the sulfonylureas. Diabetes. 1957 Jan-Feb; 6(1):60; discussion, 62. PMID: 13397425.
      Citations:    
    108. COLWELL AR, COLWELL AR, COLWELL JA. Intrapancreatic perfusion of the antidiabetic sulfonylureas. Metabolism. 1956 Nov; 5(6 Part 2):749-56. PMID: 13378043.
      Citations:    
    Colwell's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (303)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _